Literature DB >> 9799056

Adverse drug reactions (ADRs) in hospitalized pediatric patients. A prospective study.

G González-Martin1, C M Caroca, E Paris.   

Abstract

The aim of this study was to determine the frequency and the characteristics of ADRs in 219 hospitalized pediatric patients, using an intensive and prospective drug surveillance method. The frequency of ADRs in these patients was 13.7%. The systems most commonly affected were the gastrointestinal (32.5%), the central nervous (20.0%), and the metabolic systems (17.5%). Asparaginase, methotrexate, phenytoin, phenobarbital, erythromycin, and salbutamol were probably the drugs associated with the ADRs. According to causality, 54.2% of the ADRs were regarded as probable, and 32.2% as possible. The majority of the ADRs were moderate (51.2%), 27.9% were severe. The main treatment of the ADRs was the withdrawal of the suspected drugs. The length of the stay in the hospital and the total number of drugs given to the patients influenced significantly the frequency of ADRs. 93% of the ADRs were dose-dependent.

Entities:  

Mesh:

Year:  1998        PMID: 9799056

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther        ISSN: 0946-1965            Impact factor:   1.366


  15 in total

1.  Frequency of adverse drug reactions in children: a prospective study.

Authors:  Annie Pierre Jonville-Béra; Bruno Giraudeau; Pascal Blanc; Frèdèrique Beau-Salinas; Elisabeth Autret-Leca
Journal:  Br J Clin Pharmacol       Date:  2002-02       Impact factor: 4.335

2.  Risk factors associated with adverse drug reactions in hospitalised children: international multicentre study.

Authors:  Asia N Rashed; Ian C K Wong; Noel Cranswick; Stephen Tomlin; Wolfgang Rascher; Antje Neubert
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

3.  Retrospective Analysis of Pattern of Cutaneous Adverse Drug Reactions in Tertiary Hospital of Pauri Garhwal.

Authors:  Deepak Dimri; Rangeel Singh Raina; Swati Thapliyal; Vijay Thawani
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 4.  Identifying genomic and developmental causes of adverse drug reactions in children.

Authors:  Mara L Becker; J Steven Leeder
Journal:  Pharmacogenomics       Date:  2010-11       Impact factor: 2.533

5.  Adverse Drug Reactions in Children--International Surveillance and Evaluation (ADVISE): a multicentre cohort study.

Authors:  Asia N Rashed; Ian C K Wong; Noel Cranswick; Barbara Hefele; Stephen Tomlin; John Jackman; Kenneth Lee; Kam-Lun E Hon; Jeffrey Ong; Maisoon Ghaleb; Siew Siang Chua; Tea Ming Hui; Wolfgang Rascher; Antje Neubert
Journal:  Drug Saf       Date:  2012-06-01       Impact factor: 5.606

6.  Adverse drug reactions to antiretroviral therapy: prospective study in children in sikasso (mali).

Authors:  Aboubacar A Oumar; Korotoumou Diallo; Jean P Dembélé; Lassana Samaké; Issa Sidibé; Boubacar Togo; Mariam Sylla; Anatole Tounkara; Sounkalo Dao; Paul M Tulkens
Journal:  J Pediatr Pharmacol Ther       Date:  2012-10

7.  Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001-2010: content and utility analysis.

Authors:  Daniel B Hawcutt; Nicki-Jayne Russell; Hannah Maqsood; Koushan Kouranloo; Simon Gomberg; Catriona Waitt; Andrew Sharp; Andrew Riordan; Mark A Turner
Journal:  Br J Clin Pharmacol       Date:  2016-09-12       Impact factor: 4.335

Review 8.  Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.

Authors:  P Impicciatore; I Choonara; A Clarkson; D Provasi; C Pandolfini; M Bonati
Journal:  Br J Clin Pharmacol       Date:  2001-07       Impact factor: 4.335

9.  Off-label and unlicensed drug utilization in hospitalized children in Fortaleza, Brazil.

Authors:  Djanilson Barbosa Santos; Antonio Clavenna; Maurizio Bonati; Helena Lutescia Luna Coelho
Journal:  Eur J Clin Pharmacol       Date:  2008-08-07       Impact factor: 2.953

10.  Adverse drug reaction monitoring in a secondary care hospital in South India.

Authors:  R Arulmani; S D Rajendran; B Suresh
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.